*Data based on the number of users worldwide for FreeStyle Libre family of personal CGMs compared to the number of users for other leading personal CGM brands and based on CGM sales dollars compared to other leading personal CGM brands.

^†Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.

^‡The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Use of the FreeStyle LibreLink app requires registration with LibreView.

^§In comparison to FreeStyle Libre system (10 day).

^ǁThe reader can capture data from the sensor when it is within 1 cm to 4 cm of the sensor.

^¶The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

^#Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.

**Based on the sensor being replaced once every 14 days, and scanned at least once every 8 hours.

^††Default range is 70-180 mg/dL. Consult with a healthcare professional on individual target glucose range.

^‡‡Choose a site that is at least 2.5 cm (1 inch) away from an insulin injection site.

^§§CAUTION: The Sensor Pack and Sensor Applicator have the same sensor code. The sensor codes should be checked to ensure they match before using Sensor Pack and Sensor Applicator. Do not use Sensor Packs and Sensor Applicators with different Sensor codes together as this will result in incorrect glucose readings.

^ǁǁDo NOT use if the Sensor Pack or the Sensor Applicator seem to be damaged or already opened. Do NOT use if past expiration date.

^¶¶The Sensor Applicator now contains a needle. Do not touch inside the Sensor Applicator or put it back into the Sensor Pack.

^##Do not push down on the Sensor Applicator until placed over prepared site to prevent unintended results or injury.

***Applying the Sensor may cause bruising or bleeding. If there is bleeding that does not stop, remove the Sensor, and apply a new one at a different site.

^{††† or ♢}Eligible patients will receive one (1) FreeStyle Libre 14 day sensor or one (1) FreeStyle Libre 2 sensor and reader at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is not available for patients with gestational diabetes. Only patients 18 and older are eligible to receive an offer for the FreeStyle Libre 14 day sensor, and patients 4 and older are eligible to receive an offer for the FreeStyle Libre 2 sensor and reader. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs or residents of Massachusetts, Puerto Rico and other US territories. The free FreeStyle Libre 14 day sensor or FreeStyle Libre 2 sensor and reader is provided as a sample and is limited to one NDC per eligible person. The FreeStyle Libre 14 day sensor or FreeStyle Libre 2 sensor and reader cannot be re-sold, traded nor submitted to any third party payer for reimbursement and is not provided as any inducement for future purchases. The free sample card is not health insurance.

^‡‡‡Participating pharmacies are subject to change without notice. Product availability may vary by retailer.

References: 1. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (February 2017): 55-73. https://doi.org/10.1007/s13300-016-0223-6. 2. Kroeger, Jens, Peter Fasching, and Helene Hanaire. "Three European Retrospective Real-World Chart Review Studies to Determine the Effectiveness of Flash Glucose Monitoring on HbA1c in Adults with Type 2 Diabetes." Diabetes Therapy 11, no. 1 (January 2020): 279-291. https://doi.org/10.1007/s13300-019-00741-9. 3. Evans, Mark, et al. "The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-analysis of Clinical Trials and Real-world Observational Studies." Diabetes Therapy 11, no. 1 (January 2020): 83-95. DOI: 0.1007/s13300-019-00720-0. 4. Dunn, Timothy C., et al. "Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycemic measures: A European analysis of over 60 million glucose tests." Diabetes Research and Clinical Practice 137, no. 37 (March 2018): 37-46. https://doi.org/10.1016/j.diabres.2017.12.015. 5. FreeStyle Libre 14 day User's Manual. 6. Alva, Shridhara, Ting Chen, and Andrew Naegeli. "Acetaminophen Interference on ISF Based Glucose Monitoring Systems." Poster presentation presented at the Advanced Technologies & Treatments for Diabetes (ATTD), Paris, France, February 15-18, 2017.

ADC-10428 Ver 7.0 04/21